Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$18,218,257
+$16,378,434 QoQ
Shares Held
50,310
+862.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#399
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. AMGN ranks #8 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
This page
|
50,310 | $18,218,257 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,218,257 | 50,310 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,839,823 | 5,229 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,868,940 | 5,710 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $856,194 | 3,034 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $284,794 | 1,020 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $567,955 | 1,823 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $595,823 | 2,286 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $229,412 | 712 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $218,089 | 698 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $30,136 | 106 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $30,242 | 105 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $28,488 | 106 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,091 | 95 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,383 | 105 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $21,273 | 81 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $18,708 | 83 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,102,392 | 4,531 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $1,094,719 | 4,527 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,016,414 | 4,518 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,012,001 | 4,759 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,131,000 | 4,640 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $1,063,150 | 4,624 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,205,735 | 4,744 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,340,864 | 5,685 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,195,701 | 5,898 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||